Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|October 17, 2022
Correlation of antigen-specific immune response with disease severity among COVID-19 patients in BangladeshTaufiqur Rahman Bhuiyan, Hasan Al Banna, M Hasanul Kaisar, et al.
Science Immunology|December 8, 2023
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19Curtis Cai, Yu Gao, Sarah Adamo, et al.
Science Immunology|June 28, 2020
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndromeDaniela Weiskopf, Katharina S Schmitz, Matthijs P Raadsen, et al.
Cell Reports|December 26, 2019
Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue DiseaseYuan Tian, Grégory Seumois, Luzia M De-Oliveira-Pinto, et al.
Viruses|February 26, 2022
Involvement of Th1Th17 Cell Subpopulations in the Immune Responses of Mothers Who Gave Birth to Children with Congenital Zika Syndrome (CZS)Iury Amancio Paiva, Débora Familiar-Macedo, Jéssica Badolato-Corrêa, et al.
Nature Communications|November 15, 2017
Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RAYuan Tian, Mariana Babor, Jerome Lane, et al.
Frontiers in Immunology|December 17, 2020
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19Karel F A Van Damme, Simon Tavernier, Nele Van Roy, et al.
Cell Host & Microbe|February 16, 2022
Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination statusEsther Dawen Yu, Eric Wang, Emily Garrigan, et al.
JCI Insight|November 15, 2022
Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responsesSydney I Ramirez, Alba Grifoni, Daniela Weiskopf, et al.
Nature Communications|September 22, 2019
Time elapsed between Zika and dengue virus infections affects antibody and T cell responsesErick X Pérez-Guzmán, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Pageof 23